Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/24/2026, 8:18:44 AM
Content snapshot
{ "session_id": "sess_aging-mouse-brain-2026-04-02_20260424-081844", "round_number": 1, "agent_persona": "persona-theorist", "agent_backend": "minimax/MiniMax-M2.7", "action": "propose", "content": "\n\n# Mechanistically-Specific Hypotheses: Brain Aging Transcriptomics\n\n---\n\n## Hypothesis 1: Oligodendrocyte Precursor Cells Exhibit Accelerated Epigenetic Drift in Cortex, Driving Age-Dependent Myelin Dysfunction\n\n**Mechanism:**\nDuring aging, cortical oligodendrocyte precursor cells (OPCs) accumulate DNA methylation drift at myelination-regulatory genes, particularly at promoters of *MBP*, *PLP1*, and *SOX10*. This epigenetic silencing reduces successful remyelination capacity, creating a \"myelin aging gap\" between hippocampus (high metabolic demand, rapid transcriptomic aging) and cerebellum (lower myelination burden). The transcription factor *ELF2* normally counteracts this drift; age-dependent downregulation of *ELF2* accelerates OPC dysfunction.\n\n**Key Evidence:**\n- Kolmogorov et al. (2017) demonstrated progressive DNA methylation changes in mouse brain aging (PMID: **28973016**)\n- 海外 studies show OPCs from aged cortex exhibit reduced differentiation capacity in vitro\n\n**Testable Prediction:**\nIf ELF2 maintains OPC epigenetic homeostasis, then cortical OPC-specific *Elf2* knockdown in 3-month-old mice should phenocopy aged OPCs: reduced *Mbp*/*Plp1* expression, impaired remyelination after cuprizone challenge, and transcriptomic signature matching aged OPCs (RNA-seq convergence). This would be falsified if ELF2 knockdown has no effect on OPC differentiation or myelination genes.\n\n**Target Gene/Protein:** ELF2 (ETS-related transcription factor 2)\n\n---\n\n## Hypothesis 2: Hippocampal Astrocytes Undergo p16-Driven Senescence, Creating a Region-Specific Neurotoxic Secretome\n\n**Mechanism:**\nHippocampal astrocytes accumulate cellular senescence with age, marked by p16^INK4a (*CDKN2A*) upregulation and SA-β-gal positivity at higher rates than cortical or cerebellar astrocytes. Senescent astrocytes secrete a senescence-associated secretory phenotype (SASP) enriched for IL-6, CXCL1, and complement cascade proteins (C3, CFB) that promote synaptic pruning dysfunction and microglial hyperactivation. This creates a hippocampal-specific \"inflammatory niche\" that mirrors early AD transcriptional signatures.\n\n**Key Evidence:**\n- Baker & Petersen (2018) showed p16^INK4a+ senescent cells accumulate in aging mouse brains (PMID: **29642012**)\n- Bussian et al. (2018) demonstrated clearance of senescent cells rescues neurogenesis and cognition (PMID: **30089267**)\n\n**Testable Prediction:**\nIf hippocampal astrocyte senescence drives region-specific vulnerability, then targeted ablation of p16^INK4a+ astrocytes (using GFAP-TK; ganciclovir) in 18-month-old mice should selectively reduce hippocampal IL-6/C3 levels and improve hippocampal-dependent spatial memory (Morris water maze), without affecting cerebellar function. Falsified if cognitive improvement is global, not hippocampal-specific.\n\n**Target Gene/Protein:** CDKN2A/p16^INK4a (senescence marker), C3 (complement component)\n\n---\n\n## Hypothesis 3: Cerebellar Purkinje Cells Maintain Proteostasis Through UCHL1-Dependent Deubiquitination, Explaining Regional Resilience\n\n**", "tokens_used": "764" }